Business Introduction At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines,
Global Regulatory Affairs Manager Closing Date: 3rd September 2026 (COB) Business Introduction At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade.
Regulatory Affairs Manager, Oncology Therapeutic Group, Global Regulatory Affairs Closing Date: 7th September 2026 (COB) Business Introduction At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by